MHMS FIJI
MHMS FIJI

Press Release

New analysis by Public Health England – Delta (B.1.617.2) Variant

New analysis by Public Health England has shown that 2 doses of COVID-19 vaccines are highly effective against hospitalization from the Delta (B.1.617.2) variant.

The analysis suggests that the Oxford-AstraZeneca vaccine is 92% effective against hospitalization after 2 doses.

As per the initial guidelines from the World Health Organization, the second dose of the AstraZeneca COVID-19 vaccines should be administered at an interval of 8-12 weeks after an individual receives the first dose.

Currently, Fiji is confronted with widespread community transmission that is contributing to a significant rise in the number of deaths due to severe illness from COVID-19.

As a result, the Ministry of Health and Medical Services has made a decision in line with the WHO guidelines to reduce the second dose interval period for the AstraZeneca vaccine to 8 weeks from 12 weeks.

Reducing the second dose interval period of the AstraZeneca vaccines to 8 weeks will provide earlier yet strong protection to reduce severe illness, hospitalization, and death by the COVID-19 Delta variant.

The vaccine works best against mild and severe disease when the interval is 8 to 12 weeks. THE UK STUDY HAS INDICATED THAT WITH THE DELTA VARIANT MOST OF THE PROTECTION AGAINST HOSPITALISATION AND SEVERE DISEASE WITH THE ASTRAZENECA VACCINE WAS EQUALLY EFFECTIVE WHEN GIVEN AT 8 WEEKS THAN AT 12 WEEKS. We currently average 4 to 5 deaths per day which indicates an extremely high level of community transmission in the Central Division that WILL eventually spread to other areas throughout Fiji. Given the escalating nature of the epidemic, everyone needs to take cover as early as possible.

Therefore, administering the second dose at the 8th week does not reduce the effectiveness of the AstraZeneca vaccine and will provide the same level of immunity against the Delta variant.

The decision is validated by the Inter-Agency Coordination Committee in Fiji that comprises of key stakeholders including, World Health Organization, SPC (Pacific Community), Australian Government Department of Foreign Affairs and Trade, MFAT, and UNICEF.

COVID-19 Update – 18-07-2021

Media Release

COVID-19 Daily Update

Sunday, 18h July 2021

Transmission Update

We have 1,043 new cases of COVID-19 to report for the 24 hour period that ended at 8 am today. A full breakdown of areas of interest will be published online tonight on the Ministry’s COVID-19 dashboard and on the Fijian Government Facebook page. You will also be able to view the approximate locations of the new cases on the dashboard tomorrow at the following link: http://bit.ly/3vE2ZBb.

We also have 13 new COVID-19 deaths to report for the period of 14th July to 17th July.

The first COVID-19 death to report is a 77-year-old woman from Toorak. She presented to the CWM Hospital Emergency Department in severe respiratory distress. Her condition worsened in the hospital and she died on the same day (17/07/2021). She was not vaccinated.

The second COVID-19 death to report is a 49-year-old man from Vatuwaqa. He presented to the CWM Hospital Emergency Department in severe respiratory distress. His condition worsened in the hospital and he died on the same day (15/07/2021). He received the 1st dose of the vaccine on the 14th of June. He had not received the 2nd dose of the vaccine. This means that he was not fully vaccinated.

The third COVID-19 death to report is an 88-year-old woman from Nasinu who died at home on 14/07/2021. She was not vaccinated.

The fourth COVID-19 death to report is a 68-year-old man from Cunningham. He was brought to the FEMAT field hospital on 16/07/2021 and declared dead on arrival by the attending medical officer. This means that he died at home or on his way to the hospital. His family reported that he had been unwell, with symptoms including fever, cough, and shortness of breath for at least 7 days at home. He was not vaccinated.

The fifth COVID-19 death to report is a 76-year-old man from Laucala Beach. He was brought to the FEMAT field hospital and noted to be in severe respiratory distress. His condition worsened in the FEMAT field hospital and he died on the same day (16/07/2021). His family reported that he had been feeling unwell with a cough at home. He received his 1st dose of the vaccine on 29/06/2021. He had not received the  2nd dose of the vaccine. This means that he was not fully vaccinated.

The sixth COVID-19 death to report is a 65-year-old woman from Kinoya. She presented to the FEMAT field hospital in severe respiratory distress. Her condition worsened in the FEMAT field hospital and she died on the same day (17/07/2021). She received the 1st dose of the vaccine in early June. She had not received the 2nd dose of the vaccine. This means that she was not fully vaccinated.

The seventh COVID-19 death to report is a 69-year-old woman from Samabula. She presented to a medical facility in severe respiratory distress. She was retrieved by a medical team to the FEMAT field hospital. Her condition worsened in the FEMAT field hospital and she died on the same day (17/07/2021). She received the 1st dose of the vaccine in early July. She had not received the 2nd dose of the vaccine. This means that she was not fully vaccinated.

The eighth COVID-19 death to report is a 86 year old man from Valelevu who died at home on 17/07/2021. He was not vaccinated.

The ninth COVID-19 death to report is an 84-year-old woman from Raiwaqa who died at home on 17/07/2021. She was not vaccinated.

The tenth COVID-19 death to report is a 60-year-old woman from Nausori She presented to a medical facility in severe respiratory distress. Her condition worsened at the medical facility and she died on the same day (17/07/2021). She was not vaccinated.

The eleventh COVID-19 death to report is a 77-year-old woman from Narere. She presented to a medical facility in severe respiratory distress. Her condition worsened at the medical facility and she died on the same day (14/07/2021). Her family reported that she was unwell with COVID-19 symptoms two days before. She was not vaccinated.

The twelfth COVID-19 death to report is a 63-year-old man from Valelevu who died at home (15/07/2021). His family reported that he had been unwell with COVID-19 symptoms (cough and shortness of breath). He received the 1st dose of the vaccine in early June. He had not received the 2nd dose of the vaccine. This means that he was not fully vaccinated.

The thirteenth COVID-19 death to report is a 70-year-old woman from Toorak who died at home on 15/07/2021. She was not vaccinated.

There have been 7 more deaths of COVID-19 positive patients. However, their deaths have been classified as non-COVID deaths by their doctors. Doctors have determined that these deaths were caused by serious pre-existing medical conditions and not COVID-19.

There have now been 98 deaths due to COVID-19 in Fiji, with 96 of these deaths during the outbreak that started in April this year. We also have recorded 41 COVID-19 positive patients who died from the serious medical conditions that they had before they contracted COVID-19; these are not classified as COVID-19 deaths.

There have been 388 new recoveries reported since the last update, which means that there are now 13,610 active cases. There have been 17,444 cases during the outbreak that started in April 2021. We have recorded a total of 17,514 cases in Fiji since the first case was reported in March 2020, with 3,765 recoveries.

There are 9 more deaths currently under investigation. These will be discussed once investigations (including test results) and classifications are complete.

Screening Update

A total of 3,795 individuals were screened and 1,068 swabbed at our stationary screening clinics in the last 24 hours, bringing our cumulative total to 322,714 individuals screened and 55,408 swabbed to date. Our mobile screening teams screened a total of 207 individuals and swabbed 290 in the last 24 hours. This brings our cumulative total to 716,965 individuals screened and 61,756 swabbed by our mobile teams to date.

Testing update

A total of 225,366 samples have been tested since this outbreak started in April 2021, with 268,227 tested since testing began in March 2020. 4407 tests have been reported for July 16th. Testing number data for one laboratory is still pending for July 15th. Based on available testing numbers, the national 7-day daily test average is 3860 tests per day or 4.4 tests per 1,000 population. The national 7-day average daily test positivity is 24% and continues on an upward trend.

Vaccination Update

As of the 17th July 393,095 adults in Fiji have received their first dose of the vaccine and 78,624 have received their second doses. This means that 67% of the target population have received at least one dose and 13.4 % are now fully vaccinated nationwide.

Fijians can check the Ministry’s vaccine dashboard to find real-time data on first-dose and second-dose numbers at the national, divisional and sub-divisional levels. You can access the live dashboard at http://bit.ly/3h2JfCZ

Epidemic Outlook

The 7-day average of new cases per day is 1000 cases per day or 1130 cases per million population per day.  Average daily case numbers are increasing, together with cases of severe disease and deaths.  

Advice to the public

In the Suva-Nausori Containment Zone, people with severe COVID-19 are still dying at home, or they are coming to a medical facility in the late stages of severe illness. Severe COVID-19 is a medical emergency, and a delay in receiving appropriate medical treatment reduces your chance of recovering from the disease.

We need all Fijians to know the severe symptoms of COVID-19, which include the following:

  •             Difficulty breathing
  •             Persistent pain or pressure in the chest
  •             Severe headache for a few days
  •             New confusion, inability to wake or stay awake
  •             Pale, gray, or blue-colored skin, lips, or nail beds

In the Suva-Nausori Containment zone, we have identified health facilities specifically designated to receive people with symptoms of severe COVID-19. If you or a loved one live in the Suva-Nausori Containment Zone and have any of these severe symptoms please go immediately to the designated health facilities listed below.

– Colonial War Memorial Hospital (CWMH)

– FEMAT Hospital, Vodafone Arena

Individuals in Nausori with severe symptoms should go to:

– Nausori Health Centre

-Wainibokasi Hospital

Call 165 if you are unable to travel to a medical facility. 

 

 

Moderna COVID-19 Vaccines Prioritized

18 July 2021

Moderna COVID-19 Vaccines Prioritized for Pregnant Women in High-Risk Areas

Beginning Wednesday, 21 July 2021, the Ministry of Health and Medical Services will administer the Moderna COVID-19 vaccines to pregnant women across Viti Levu.

Due to the increasing widespread transmission of COVID-19 disease across Viti Levu, pregnant women are at a higher risk of contracting the virus which may cause severe illness.

As a result, these women are prioritized for receiving the Moderna vaccines that provide earlier protection against the disease due to its shorter interval period of 28 days between the first and the second dose.

Pregnant women who are employed as civil servants and are waiting to receive their COVID-19 vaccines, may continue to go to work as they will be temporarily exempted until August 1st 2021.

For vaccination, pregnant women must provide their antenatal care clinic card as an evidence of pregnancy and booking done with the Ministry of Health and Medical Services.

The Ministry of Health recommends that pregnant women living outside Viti Levu must continue to receive the AstraZeneca COVID-19 vaccines.

Additionally, Fiji has recorded high number of deaths of individuals aged 60 years and above, particularly those with comorbidity issues as a result of severe illness from COVID-19. These deaths were mainly recorded within the Suva-Nausori corridor where the transmission is widespread.

Therefore, to provide earlier protection to the remaining unvaccinated vulnerable group within the Suva-Nausori corridor, the Moderna vaccines will be administered to individuals above 60 years of age residing in Suva-Nausori corridor, particularly those with comorbidities such as chronic lung disease, significant cardiac disease, severe obesity, diabetes, liver disease and human immunodeficiency virus (HIV) infection.

Further information in relation to the roll out of the Moderna vaccine will be provided by the Ministry of Health soon.

Ends.

COVID-19 Vaccine – 2nd Dose Interval

18th July 2021

Media Release

The second dose interval period brought forward to the 8th week

Individuals who receive the first dose of the AstraZeneca COVID-19 vaccine can now receive their second dose after an interval of 8 weeks instead of 12 weeks.

The decision has been made by the Ministry of Health and Medical Services following the latest research which shows that administering the second dose of the COVID-19 vaccines at the minimum interval of 8 weeks provides the same level of protection as compared to the 12th week.

The decision to administer the second dose of AstraZeneca vaccines at 8 weeks is intended for providing earlier protection to reduce severe illness, hospitalization, and death by the concerning Delta Variant in the country.

Initially, the second dose of AstraZeneca COVID-19 vaccines could be administered at an interval of 8-12 weeks.

Administering the second dose at the 8th week will not affect the effectiveness of the vaccine and will provide the same level of immunity against the delta variant. Additionally, it will provide earlier protection against severe illness, hospitalization, and death from COVID-19.

Individuals who have received their first dose and were scheduled to take their second dose at an interval of 12 weeks will receive a reminder via text message in the 8th week.

The Ministry of Health reiterates that the second dose will be only provided at an interval of 8 weeks and not BEFORE. Individuals who are due for their second dose of the COVID-19 vaccines can go to their nearest vaccination site.

 

COVID-19 Update – 17-07-2021

Media Release

COVID-19 Daily Update

Saturday, 17h July 2021

Transmission Update

We have 1,180 new cases of COVID-19 to report for the 24 hour period that ended at 8am today. A full breakdown of areas of interest will be published online tonight on the Ministry’s COVID-19 dashboard and on the Fijian Government Facebook page. You will also be able to view the approximate locations of the new cases on the dashboard tomorrow at the following link: http://bit.ly/3vE2ZBb.

We also have 5 new COVID-19 deaths to report for the period of 13th July to 16th July.

The first COVID-19 death to report is a 47 year old woman from Raiwaqa. She presented to a medical facility with severe COVID-19 symptoms including shortness of breath. Her condition worsened at the health facility and she died on the same day 14/7/2021. She was not vaccinated.

The second COVID-19 death to report is a 61 year old man from Caubati. He presented to a health facility in severe respiratory distress. His condition worsened at the health facility and he died on the same day 15/7/2021. His family reported that he had been unwell with symptoms that included generalized body pains. He was not vaccinated.

The third COVID-19 death to report is a 67 year old woman from Naiyala Village. She presented to a health facility in severe respiratory distress. Her condition worsened at the health facility and she died on the same day (15/7/2021). Her family reported that she had been unwell with COVID-19 symptoms four days prior. She was not vaccinated.

The fourth COVID-19 death to report is a 61 year old woman from Valelevu. She presented to a medical facility in severe respiratory distress. Her condition worsened in the health facility and she died on the same day 16/7/2021. She received her 1st dose of the vaccine in early-June. She did not receive her 2nd dose of the vaccine. This means that she was not fully vaccinated.

The fifth COVID-19 death to report is a 66 year old woman from Lami who died at home (13/07/2021). Her family reported that she was feeling unwell with generalized muscular weakness and was noted to have a reduced appetite. She was not vaccinated.

There have now been 85 deaths due to COVID-19 in Fiji, with 83 of these deaths during the outbreak that started in April this year. We also have recorded 34 COVID-19 positive patients who died from the serious medical conditions that they had before they contracted COVID-19; these are not classified as COVID-19 deaths.

There have been 159 new recoveries reported since the last update, which means that there are now 12,975 active cases. There have been 16,401 cases during the outbreak that started in April 2021. We have recorded a total of 16,471 cases in Fiji since the first case was reported in March 2020, with 3,377 recoveries.

There are seven more deaths currently under investigation. These will be discussed once investigations (including test results) and classifications are complete.

Screening Update

A total of 6,347 individuals were screened and 1,954 swabbed at our stationary screening clinics in the last 24 hours, bringing our cumulative total to 318,919 individuals screened and 54,340 swabbed to date. Our mobile screening teams screened a total of 4,430 individuals and swabbed 611 in the last 24 hours. This brings our cumulative total to 716,758 individuals screened and 61,466 swabbed by our mobile teams to date.

Testing update

A total of 220,959 samples have been tested since this outbreak started in April 2021, with 263,820 tested since testing began in March 2020. 3409 tests have been reported for July 15th. Testing number data for one laboratory is still pending for July 15th.  Based on available testing numbers, the national 7-day daily test average is 3876 tests per day or 4.4 tests per 1,000 population. The national 7-day average daily test positivity is 21.7% and continues on an upward trend.

Vaccination Update

As of the 16th July 391,363 adults in Fiji have received their first dose of the vaccine and 77,610 have received their second doses. This means that 66.7% of the target population have received at least one dose and 13.2 % are now fully vaccinated nationwide.

Fijians can check the Ministry’s vaccine dashboard to find real-time data on first-dose and second-dose numbers at the national, divisional and sub-divisional levels. You can access the live dashboard at http://bit.ly/3h2JfCZ

Epidemic Outlook

The 7-day average of new cases per day is 921 cases per day or 1040 cases per million population per day.  Average daily case numbers are increasing, together with cases of severe disease and deaths.

Advice to the public

In the Suva-Nausori Containment Zone, people with severe COVID-19 are still dying at home, or they are coming to a medical facility in the late stages of severe illness. Severe COVID-19 is a medical emergency, and a delay in receiving appropriate medical treatment reduces your chance of recovering from the disease.

We need all Fijians to know the severe symptoms of COVID-19, which include the following:

  •             Difficulty breathing
  •             Persistent pain or pressure in the chest
  •             Severe headache for a few days
  •             New confusion, inability to wake or stay awake
  •             Pale, gray, or blue-coloured skin, lips or nail beds

In the Suva-Nausori Containment zone we have identified health facilities specifically designated to receive people with symptoms of severe COVID-19. If you or a loved one live in the Suva-Nausori Containment Zone and have any of these severe symptoms please go immediately to the designated health facilities listed below.

– Colonial War Memorial Hospital (CWMH)

– FEMAT Hospital, Vodafone Arena

Individuals in Nausori with severe symptoms should go to:

– Nausori Health Centre

-Wainibokasi Hospital

Call 165 if you are unable to travel to a medical facility.